GenomicsNature CommunicationsPeer-reviewed
Single-cell analysis of severe COVID-19 patients reveals a monocyte-driven inflammatory storm attenuated by Tocilizumab
Chuang Guo, Bin Li, Huan Ma…·Kun Qu
The paper uses single-cell analysis to show that Tocilizumab reduces monocyte-driven inflammation in severe COVID-19 but does not fully suppress immune responses.